Detailed information for compound 606120

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 385.371 | Formula: C19H19N3O6
  • H donors: 1 H acceptors: 3 LogP: 2.75 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(NC(=O)Cn2ccc3c2cc(cc3)[N+](=O)[O-])cc(c1OC)OC
  • InChi: 1S/C19H19N3O6/c1-26-16-8-13(9-17(27-2)19(16)28-3)20-18(23)11-21-7-6-12-4-5-14(22(24)25)10-15(12)21/h4-10H,11H2,1-3H3,(H,20,23)
  • InChiKey: KYKPESNPVOJSBK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus tar DNA binding protein 0.0331 0.9741 0.9741
Schistosoma mansoni hypothetical protein 0.0175 0.433 0.433
Echinococcus multilocularis tar DNA binding protein 0.0331 0.9741 0.9741
Loa Loa (eye worm) hypothetical protein 0.0339 1 1
Brugia malayi TAR-binding protein 0.0331 0.9741 0.9741
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0331 0.9741 0.9741
Schistosoma mansoni tar DNA-binding protein 0.0331 0.9741 0.9741
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0236 0.6439 0.5
Echinococcus multilocularis geminin 0.0175 0.433 0.433
Brugia malayi RNA recognition motif domain containing protein 0.0331 0.9741 0.9741
Loa Loa (eye worm) RNA binding protein 0.0331 0.9741 0.9741
Echinococcus multilocularis high affinity choline transporter 1 0.0339 1 1
Loa Loa (eye worm) TAR-binding protein 0.0331 0.9741 0.9741
Echinococcus multilocularis tumor protein p63 0.0335 0.9867 0.9867
Echinococcus granulosus tumor protein p63 0.0335 0.9867 0.9867
Schistosoma mansoni tar DNA-binding protein 0.0331 0.9741 0.9741
Schistosoma mansoni high-affinity choline transporter 0.0339 1 1
Schistosoma mansoni tar DNA-binding protein 0.0331 0.9741 0.9741
Schistosoma mansoni hypothetical protein 0.0175 0.433 0.433
Echinococcus granulosus high affinity choline transporter 1 0.0339 1 1
Schistosoma mansoni tar DNA-binding protein 0.0331 0.9741 0.9741
Schistosoma mansoni tar DNA-binding protein 0.0331 0.9741 0.9741
Echinococcus granulosus geminin 0.0175 0.433 0.433
Brugia malayi RNA binding protein 0.0331 0.9741 0.9741

Activities

Activity type Activity value Assay description Source Reference
CC50 (functional) > 10 uM Huh7 cytotoxicity for Pf inhibitors Novartis-GNF Malaria Box. No reference
CC50 > 10 uM NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) ChEMBL. 18579783
EC50 (functional) = 0.319 uM W2 Pf proliferation inhibition Novartis-GNF Malaria Box. No reference
EC50 (functional) = 0.319 uM NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay ChEMBL. 18579783
EC50 (functional) = 0.439 uM PF proliferation inhibition 3D7 Novartis-GNF Malaria Box. No reference
EC50 (functional) = 0.439 uM NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ChEMBL. 18579783
IFI promiscuity index = 0.0303 IFI promiscuity index Novartis-GNF Malaria Box. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23 18579783

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.